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Real-Time Quantification and Display of Skin Radiation
During Coronary Angiography and Intervention
Ad den Boer, BS; Pim J. de Feijter, MD; Patrick W. Serruys, MD; Jos R.T.C. Roelandt, MD
Background—Radiographically guided investigations may be associated with excessive radiation exposure, which may
cause skin injuries. The purpose of this study was to develop and test a system that measures in real time the dose applied
to each 1-cm2 area of skin, taking into account the movement of the x-ray source and changes in the beam characteristics.
The goal of such a system is to help prevent high doses that might cause skin injury.
Methods and Results—The entrance point, beam size, and dose at the skin of the patient were calculated by use of the
geometrical settings of gantry, investigation table, and x-ray beam and an ionization chamber. The data are displayed
graphically. Three hundred twenty-two sequential cardiac investigations in adult patients were analyzed. The mean peak
entrance dose per investigation was 0.475 Gy to a mean skin area of 8.2 cm2. The cumulative KERMA-area product per
investigation was 52.2 Gy/cm2 (25.4 to 99.2 Gy/cm2), and the mean entrance beam size at the skin was 49.2 cm2.
Twenty-eight percent of the patients (90/322) received a maximum dose of ,1 Gy to a small skin area (’6 cm2), and
13.5% of the patients (42/322) received a maximum dose of .2 Gy.
Conclusions—Monitoring of the dose distribution at the skin will alert the operator to the development of high-dose areas;
by use of other gantry settings with nonoverlapping entrance fields, different generator settings, and extra collimation,
skin lesion can be avoided. (Circulation. 2001;104:1779-1784.)
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Coronary arteriography and x-ray–guided catheter-basedinterventions are increasingly used. X-ray exposure may
be associated with adverse effects, however, as described as
early as 1897.1 Numerous incidents of radiation-induced skin
injuries have recently been reported.2–14 Doses from the
prolonged use of fluoroscopy can be very high and place the
skin at risk for injury. Even though some modern x-ray
equipment uses dose-saving measures, such as added filtra-
tion and dose-reducing variable-pulsed fluoroscopy, compli-
cated procedures can still result in high-risk skin doses. It is
therefore important to reduce radiation exposure as much as
possible.15–20
Newer x-ray units have an integrated ionization chamber
that allows monitoring of the kinetic energy released in
matter (KERMA; the absorbed dose in air)–area product, but
the entrance dose and dose distribution at the skin are not
indicated. Therefore, there is a need to monitor and to
quantify the skin radiation dose.21–30
We have developed a system that automatically measures
and monitors the accumulated skin radiation dose and allows
detection of high-dose areas in real time.
In this study, the feasibility and usefulness of this tech-
nique have been investigated by analysis of the frequency
distribution of high-dose areas in consecutive patients under-
going percutaneous intracoronary procedures.
Methods
Study Patients
The radiation monitoring system was installed in 2 of our interven-
tional laboratories. We were able to collect and analyze complete
data from 322 consecutive adult patients (235 men, 87 women; mean
age 59 years, range 50 to 69 years). Patient height was 174 cm (range
168 to 180 cm), weight 79 kg (range 70 to 87 kg), and obesity
(Quetelet) index 26 (range 24 to 28). Of these, 134 patients
underwent a diagnostic procedure and 188 patients an intracoronary
intervention (60 patients with a right coronary artery, 75 a left
circumflex, and 39 a left anterior descending [LAD] stenosis). Nine
patients had bypass grafts, and 5 had a total occlusion.
Procedures
We developed a mathematical model to calculate the x-ray entrance
field and the location of the irradiated areas of the skin. To be able
to measure the x-ray dose for each 1 cm2 of irradiated surface, the
following assumptions are made:
1. The patient position (5skin position) is defined by the location
of the floating tabletop, and it is further assumed that the
patient does not change position during the investigation.
2. Patients are considered to have a circular thorax with a
circumference of 90 cm (only adult patients are examined).
The following parameters for radiation monitoring are measured:
1. Table: Patient position and the tabletop (measured in a 3D
plane in millimeters, with the floor as reference).
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2. Gantry: Rotation and angulation in degrees and source-image
distance and isocentric elevation from the floor in millimeters.
3. Collimator: X-ray beam size, horizontal and vertical, in milli-
meters and the KERMA-area product (KAP; sometimes called
dose-area product) value in grays per square centimeters.
4. Generator: X-ray mode and fluoroscopy time (continuous or
pulsed) or (digital) cine pulses.
The entrance beam location at the skin was derived from the
distance from the x-ray focal spot to the patient in the transverse
plane by use of the gantry rotation, focal spot position, and patient
position. This distance was corrected for the gantry angulation in the
longitudinal plane. The entrance beam size was calculated from the
collimator beam dimensions.
The radiation dose at the skin was calculated in grays by use of the
entrance beam dimensions and the KAP, measured with an ioniza-
tion chamber in the collimator.
The theoretical mathematical model is not presented in this article
but is available from the authors. The model is used in a monitor
system developed by the Siemens Co, the prototype of which is used
to retrieve the data.
Graphical Display
Figure 1 shows a 3D graph with the dose distribution at a 50350-cm
dorsal aspect of the skin after an interventional procedure involving
the LAD, including implantation of 2 stents. This graph was
generated with our prototype system during a pilot study. The
graphical display of the system used for data accumulation during
our study shows a skin area of 90390 cm.
Figure 2 is a plot of skin dose depicted in a 2D plane centered over
the backbone; the skin surface is virtually split at the sternum and
shown laid flat. This graph is automatically displayed on the x-ray
monitor after radiation of any part of the skin exceeds a level of 1
Gy. The irradiated skin area is continuously displayed and updated,
even when fluoroscopy is not used. This enables the physician to
change gantry settings or use extra collimating to avoid possible
overlapping with previously irradiated skin parts without using
radiation.
Entrance Beam Dimensions
Both units have automated collimation that limits the beam area to
the selected field of view of the image intensifier, independent of
TABLE 1. Maximal Possible Beam Size per Image-Intensifier
Screen and Skin
Used image-intensifier field, cm 23 17 13
Maximal beam size at entrance
screen, cm
17.9317.9 13.6313.6 10.5310.5
Maximal beam size at skin, cm 9.839.8 7.737.7 5.935.9
Maximal radiated skin area, cm2 ’100 ’60 ’35
Figure 1. Dose distribution at 50350-cm dorsal skin part after
interventional procedure from LAD, followed by implantation of
2 stents. Peak, located at right side, is due to left superior
oblique projection, most radiation absorbent projection. Size of
high-dose area .1 Gy was 19 cm2.
Figure 2. Graphical display of prototype system shows skin area of 90390 cm. Graph is automatically displayed on x-ray monitor after
radiation at any part of skin exceeds a level of 1 Gy. Dose report is integrated into this display. Actual irradiated skin area is marked as
a square on display (even without fluoroscopy), enabling physician to avoid possible overlap with previously irradiated skin parts by
extra collimating or changing gantry settings. Example shows dose distribution at skin after a procedure with 49.3 minutes of radiation
time, a PTCA of LAD. Peak entrance dose (hot spot) received by skin was 1.86 Gy to an area of 5.0 cm2.
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changes in the source-to-image distance (SID tracking). The area of
the beam at the skin, however, does change with the source-to–
image-intensifier distance. The maximum possible beam areas are
given in Table 1.
Dose Settings of the X-Ray Equipment
The dose settings for the x-ray equipment for the pulsed fluoroscopy
mode (PFM) and the digital cine mode (DCM) during the study
period are shown in Table 2. The highest possible kilovoltage peak
(kVp) during PFM was 110 kVp, and during DCM, 125 kVp. The
frequency of PFM was adjusted to 12.5 pulses per second, and the
extra beam filter used was 0.2 mm Cu.
The scattered radiation grid had a ratio of 11 and 40 line pairs per
centimeter and a focal spot distance of 950 mm and was carbon fiber
filled and covered. The radiation measurement was performed with
an ionization chamber built into the collimator, and the KAP is
shown.
Statistics
Unless otherwise stated, numerical data are presented as median with
interquartile range.
Results
Total Radiation Dose per Investigation
The cumulative KAP per investigation was 52.2 Gy/cm2
(range 25.4 to 99.2 Gy/cm2). The mean entrance beam size at
the skin was 49.2 cm2, giving an absolute value of 1.06 Gy
(Figure 3).
Radiation Time
The mean fluoroscopy time was 17.8 seconds (range 8.8 to
33.1 seconds), with pulsed fluoroscopy of 12.5 pulses per
second. The mean DCM time was 97.9 seconds (range 69.4 to
151.1 seconds), with a frequency of 12.5 frames per second.
Irradiated Skin Surface
The radiation-exposed skin area in 95% of all investigations
was restricted to a size of 50350 cm, including the irradiated
area at the groin for catheter introduction and left lateral
gantry positioning. This is shown in Figure 1. In the remain-
ing 5% of the cases, the exposed skin area could be visualized
by showing a 90390-cm area.
Peak Entrance Dose
The distribution of peak entrance skin doses to the patients in
our series is shown in Figure 4. The mean value was 0.475
Gy, with a mean area of 8.2 cm2 exposed. Dose values .1 Gy
occurred in the majority of the patients (52%), whereas parts
receiving a dose .4 Gy occurred in only 1.2%. Because our
system alerted us in real time when a high-dose area was
developing, we were able to avoid excessive dose to that area
by changing the gantry settings. It was not necessary to
interrupt any procedure as a result of a high-dose “hot spot.”
Correlation Between the Measured KAP, Patient
Obesity, and Fluoroscopy Time
The correlation between the measured KAP and the obesity
of the patient, the Quetelet index (kg/m2), was low (R50.15).
Higher doses were correlated with gantry projections that
required penetration of thick, highly absorbent body masses.
There was a strong relationship between the KAP and
fluoroscopy time (R50.78) (Figure 5).
Correlation Between Measured KAP and Peak
Entrance Dose
There was a high correlation between measured KAP and
peak entrance dose (R50.89) (Figure 6). We also compared
the correlation between KAP and the high-dose areas in the
134 diagnostic and the 188 interventional procedures. The
correlation between the interventional procedures (R50.90)
was higher than the correlation between diagnostic proce-
dures (R50.35) because of more frequent changing of gantry
settings and less overlapping of entrance fields in diagnostic
cases.
TABLE 2. Dose Settings of the X-Ray Equipment
Image-intensifier entrance field size, cm 23 17 13
PFM intensifier dose per image, nGy 10 16 28
PFM intensifier dose per second, mGy/s 0.12 0.20 0.35
DCM intensifier dose per image, nGy 63 104 174
Figure 3. KAP measured in 322 patients.
Mean value was 52.19 Gy/cm2 (range
25.4 to 99.2 Gy/cm2). Mean size of
entrance beam was 49.2 cm2.
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Validation of the Measured KAP
The ionization chamber readings were verified regularly with
other measuring devices; the accuracy of the KAP readings
was within a 5% range. The values that appear on the monitor
reflect the free-in-air KERMA, measured in grays. The dose
to the tissue is actually 30% to 40% greater than the value
displayed during monitoring, because of backscattered radi-
ation and the KERMA-to–tissue-dose conversion factor.
Discussion
Skin injury as a result of radiation exposure was reported as
early as 1897.1 The number of radiologically guided inter-
ventions is increasing, as well as the amount of radiation used
per procedure. Recent publications show an increasing num-
ber of skin injuries during cardiac, abdominal, and neurolog-
ical interventions.2–14 High entrance-dose values cannot be
avoided in complex investigations, because they often require
long exposure times.
Our method allows for skin dose management and makes it
possible to keep the dose at a certain skin area as low as
reasonable for the procedure. This is important because many
patients have more than one procedure, and skin dose
accumulates.
It should be kept in mind that a high dose may produce
unacceptable skin damage and should be avoided26–30 (Table
3). Real-time dose monitoring can prevent these adverse
effects because it allows selection of other x-ray techniques,
such as extra beam filtering, selection of lower frame rates,
and if available, documenting of low-dose fluoroscopic runs
during the procedure.15–18 Extra beam collimation is not often
used but is a highly effective way to decrease both patient and
operator radiation exposure without loss in image quality.
Finally, the use of other gantry settings allows distribution
of the radiation dose over different skin areas and prevents
development of a high dose. In our study, only 1.2% of the
patients received a dose .4 Gy at some parts of the skin. It
should be noted, however, that when equipment without
dose-saving measures is used, levels are much higher (up to
7 times).15
Limitations
The monitoring system used in this study assumed a patient
with a thorax circumference of 90 cm. Obviously, this does
Figure 5. Correlation between measured
KAP and fluoroscopy time for complete
patient group: R50.78, x5275.19,
y5327.83. With extreme values taken out,
fluoroscopy times .100 minutes showed
R50.70, x5537.42, y5296.15. Mean KAP
was 52.19; mean fluoroscopy time used
was 17.8 minutes.
Figure 4. Peak entrance dose measured
in 322 patients; mean value was 0.475
Gy. Mean size of high-dose area was 8.2
cm2.
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not apply to all patients, and ideally, a monitoring system
should be tailored to the size of the patient. The actual size
and location of irradiated skin parts may vary from one
individual to another; future refinements to model the dimen-
sions of individual patients more accurately would improve
the accuracy of the skin dose distribution.
Clinical Recommendations
Our data show that the likelihood of high-dose areas may
occur in the following circumstances: fluoroscopy time .60
minutes; gantry positioning unchanged throughout the proce-
dure; and the irradiation occurring through a highly attenu-
ating (eg, bone), thick body mass, requiring a high radiation
quality during fluoroscopy and cinematography (.110 kVp).
High-dose areas most likely occur when the left superior
oblique projection is used.
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